Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4) - Concepedia

Concepedia

Publication | Open Access

Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4)

DOI Full Paper Access

45

Citations

22

References

2023

Year

Robin Cornelissen, Arsela Prelaj, Sophie Sun, Christina S. Baik, Mirjana Wollner, Eric B. Haura, Hirva Mamdani, Jonathan W. Riess, Federico Cappuzzo, Marina Chiara Garassino,

Journal of Thoracic Oncology

Cohort 4Mendelian DisorderPathologyA MulticenterPharmacotherapyPhase 2MedicineRadiation OncologyGenetic MedicineNovel Therapy

References

	Year	Citations

Page 1

Page 1